DEFC14A: Vision One Launches Proxy Fight to Overhaul Ingevity Board, Citing Underperformance and Strategic Missteps

Vision One Fund is soliciting proxies to elect its nominees to Ingevity's board, aiming to drive change, restore governance, and enhance capital allocation strategies.

Summary

• Vision One Fund, LP is soliciting proxies for the 2025 Annual Meeting of Stockholders of Ingevity Corporation to elect Julio C. Acero and F. David Segal to the Board of Directors.
• Vision One believes board enhancement is necessary to drive change, restore good governance practices, and implement value-enhancing capital allocation strategies.
• They are also soliciting votes on executive compensation (against), ratification of PricewaterhouseCoopers LLP as the independent accounting firm (for), and the Ingevity Corporation 2025 Omnibus Incentive Plan (abstain).
• Vision One owns approximately 1.15% of Ingevity's outstanding shares as of the record date, March 3, 2025.
• Vision One is urging stockholders to vote for their nominees and withhold votes for Jean S. Blackwell and Daniel F. Sansone, while voting for the remaining company nominees.
• Vision One believes Ingevity is underperforming its peers, citing poor Total Shareholder Return (TSR) over various periods.
• Vision One criticizes Ingevity's corporate strategy, capital allocation, and executive compensation decisions.
• Vision One suggests selling the entire Performance Chemicals segment instead of just the Industrial Specialties product line.
• Vision One believes the current board is entrenched and lacks accountability, advocating for new directors with financial expertise and corporate governance safeguards.

Sentiment

Score: 3

Explanation: The document is critical of Ingevity's performance and governance, indicating a negative sentiment. While Vision One expresses a willingness to collaborate, the overall tone is adversarial due to the proxy fight.

Positives

• Vision One's nominees are expected to bring new, objective, and fully independent perspectives to the Board.
• Vision One's involvement has potentially pushed Ingevity to explore strategic alternatives for its Performance Chemicals Industrial Specialties product line.
• Vision One's nominees are committed to working collaboratively with the Company to address its challenges and drive change.

Negatives

• Ingevity's Total Shareholder Return (TSR) has been worst-in-class over various periods.
• The appointment of Luis Fernandez-Moreno as Interim President and CEO with a $3,000,000 annual base salary is considered excessive by Vision One.
• Vision One believes the current board is entrenched and lacks accountability.
• Vision One believes the sale of just the Industrial Specialties operations will significantly reduce the value of the remaining chemical assets.
• Vision One believes the Company's co-location plan introduces substantial new risk that a buyer of the Industrial Specialties product line could access and impact the proprietary operations of the Company's Road Technologies business.

Risks

• There is no guarantee that Vision One's nominees will be able to implement the changes they believe are necessary to enhance stockholder value, as they will not constitute a majority of the Board.
• The Company's proposed sale of the Industrial Specialties product line may have a disproportionately negative impact on the remaining Performance Chemicals assets.
• The Company's co-location plan introduces substantial new risk that a buyer of the Industrial Specialties product line could access and impact the proprietary operations of the Company's Road Technologies business.
• The Company may not engage in a constructive dialogue with Vision One, hindering efforts to address the Company's challenges.

Future Outlook

Vision One believes that the election of its nominees will provide stockholders with added assurance that the Board and management of Ingevity are properly focused on the challenges facing the Company and are comprehensive in their exploration of options to enhance share value.

Management Comments

• Vision One disagrees with the Company's characterization of the material events leading to this proxy solicitation and believes that the Company's characterization of such events is misleading.
• Vision One questions whether decisive action in this instance refers to the Board pushing forward with its own agenda despite a stockholder raising its concerns first privately with the Company and then publicly after the Company failed to engage in discussions with the stockholder.
• Vision One questions how committed the Company really is to resolving this matter constructively with Vision One as the Company does not appear to have seriously considered any of Vision One's proposals.

Industry Context

The document highlights Ingevity's underperformance relative to the S&P Chemicals Index and S&P Materials Index, suggesting a potential misalignment with industry trends and competitor performance.

Comparison to Industry Standards

• The document compares Ingevity's executive compensation to that of Cabot Corporation, Eastman Chemical Company, PPG Industries, Inc., and The Sherwin-Williams Company, noting that Ingevity's interim CEO's compensation is significantly higher despite having a smaller market capitalization.
• The document references Inclusive Capital Partners, L.P.'s previous involvement with Ingevity, noting that the company's stock price declined during their board representative's tenure.

Stakeholder Impact

• The outcome of the proxy fight will significantly impact Ingevity's shareholders, potentially influencing the company's stock price and future performance.
• Changes to the board and corporate strategy could affect Ingevity's employees, customers, and suppliers.

Next Steps

• Stockholders are urged to sign, date, and return the GOLD universal proxy card to elect Vision One's nominees.
• Vision One will continue to engage with Ingevity's board and management to address its concerns.
• The outcome of the Annual Meeting will determine the composition of Ingevity's board and the direction of its corporate strategy.

Key Dates

Keywords

proxy solicitation, board refreshment, corporate governance, capital allocation, shareholder value, Vision One Fund, Ingevity Corporation, directors, nominees, TSR